HCPCS J-Codes
Drugs administered other than oral method, chemotherapy drugs

These codes are used to report injectable drugs that ordinarily cannot be self-administered; chemotherapy, immunosuppressive drugs and inhalation solutions as well as some orally administered drugs.


View All HCPCS Sections
  • J1245

    Injection, dipyridamole, per 10 mg
  • J1250

    Injection, dobutamine hydrochloride, per 250 mg
  • J1260

    Injection, dolasetron mesylate, 10 mg
  • J1265

    Injection, dopamine hcl, 40 mg
  • J1267

    Injection, doripenem, 10 mg
  • J1270

    Injection, doxercalciferol, 1 mcg
  • J1271

    Injection, doxycycline hyclate, 1 mg
  • J1290

    Injection, ecallantide, 1 mg
  • J1299

    Injection, eculizumab, 2 mg
  • J1300

    Injection, eculizumab, 10 mg
  • J1301

    Injection, edaravone, 1 mg
  • J1302

    Injection, sutimlimab-jome, 10 mg
  • J1303

    Injection, ravulizumab-cwvz, 10 mg
  • J1304

    Injection, tofersen, 1 mg
  • J1305

    Injection, evinacumab-dgnb, 5mg
  • J1306

    Injection, inclisiran, 1 mg
  • J1307

    Injection, crovalimab-akkz, 10 mg
  • J1308

    Injection, famotidine, 0.25 mg
  • J1320

    Injection, amitriptyline hcl, up to 20 mg
  • J1322

    Injection, elosulfase alfa, 1 mg
  • J1323

    Injection, elranatamab-bcmm, 1 mg
  • J1324

    Injection, enfuvirtide, 1 mg
  • J1325

    Injection, epoprostenol, 0.5 mg
  • J1326

    Injection, zolbetuximab-clzb, 2 mg
  • J1327

    Injection, eptifibatide, 5 mg
  • J1330

    Injection, ergonovine maleate, up to 0.2 mg
  • J1335

    Injection, ertapenem sodium, 500 mg
  • J1364

    Injection, erythromycin lactobionate, per 500 mg
  • J1370

    Injection, esomeprazole sodium, 1 mg
  • J1380

    Injection, estradiol valerate, up to 10 mg
  • J1410

    Injection, estrogen conjugated, per 25 mg
  • J1411

    Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
  • J1412

    Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
  • J1413

    Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
  • J1414

    Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
  • J1426

    Injection, casimersen, 10 mg
  • J1427

    Injection, viltolarsen, 10 mg
  • J1428

    Injection, eteplirsen, 10 mg
  • J1429

    Injection, golodirsen, 10 mg
  • J1430

    Injection, ethanolamine oleate, 100 mg
  • J1434

    Injection, fosaprepitant (focinvez), 1 mg
  • J1435

    Injection, estrone, per 1 mg
  • J1436

    Injection, etidronate disodium, per 300 mg
  • J1437

    Injection, ferric derisomaltose, 10 mg
  • J1438

    Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
  • J1439

    Injection, ferric carboxymaltose, 1 mg
  • J1440

    Fecal microbiota, live - jslm, 1 ml
  • J1442

    Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
  • J1443

    Injection, ferric pyrophosphate citrate solution (triferic), 0.1 mg of iron
  • J1444

    Injection, ferric pyrophosphate citrate powder, 0.1 mg of iron

HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/3/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.